Health Tech

2 articles

Holographic molecular models and AI interfaces in a futuristic lab, representing accelerated drug discovery and in silico trials.

AI Drug Development Surges: In Silico Trials Market Grows Dramatically

Biotech firm Insilico Medicine used artificial intelligence to discover a novel drug candidate for idiopathic pulmonary fibrosis (IPF) and advance it to Phase I clinical trials in under 30 months, acc

Aram Sarkisian·June 6, 2026

An AI interface in a futuristic lab designing novel miniproteins that target GPCRs, showcasing a breakthrough in drug discovery.

Cosmos & Space

UW Medicine AI designs novel miniproteins targeting GPCRs

In one mouse study, a designed miniprotein performed comparably to a clinically used drug with fewer side effects, offering a glimpse into safer treatments for human diseases.

David Grossman·May 21, 2026